cyclopentyl 2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)methylamino)acetate Chemical Properties

storage temp. 

Store at -20°C

solubility 

DMSO:81.0(Max Conc. mg/mL);200.73(Max Conc. mM)
Ethanol:15.0(Max Conc. mg/mL);37.17(Max Conc. mM)

form 

A crystalline solid

color 

Light yellow to khaki

cyclopentyl 2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)methylamino)acetate Usage And Synthesis

Description

GSK3117391 is a histone deacetylase (HDAC) inhibitor (IC₅₀ = <100 nM in HeLa nuclear extracts). It inhibits growth of U937 and HUT cancer cells (IC₅₀s = <330 nM).

Uses

GSK3117391 (ESM-HDAC391) is a histone deacetylase (HDAC) inhibitor, extracted from patent WO/2008040934 A1. Target: HDAC

IC 50

HDAC

References

[1] Davidson Alan Hornsby, et al. Preparation of amino acid-based hydroxamic acids as histone deacetylase (HDAC) inhibitors. From PCT Int. Appl. (2008), WO 2008040934 A1 20080410.

cyclopentyl 2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)methylamino)acetate(1018673-42-1)Related Product Information

• GSK3008348
• 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
• GSK2983559
• GSK3175047
• GSK2982772
• GSK2894631A
• GSK-2881078
• N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide
• GSK3145095
• GSK3039294